Ritalin levels in adults with ADHD
Part of Hormones & metabolism, Mental health clinical trials.
This study looks at how methylphenidate (Ritalin) is processed in the body in adults with ADHD, and whether this differs between people with obesity and those without. It aims to help doctors give the right dose to each person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- A psychiatrist has confirmed your ADHD diagnosis.
- You have been taking a steady dose of methylphenidate (Ritalin) for at least 2 weeks.
- You are either in the obesity group (BMI 30 or higher) or non-obesity group (BMI below 30).
- You are not on certain medications like decongestants, MAOI antidepressants, or acid reflux drugs.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the brain's electrical activity may predict whether a child with ADHD will respond well to methylphenidate (Ritalin). It aims to find biological markers that could help doctors choose the right treatment sooner.
This study looks at how your genes affect your response to Methylphenidate (a common ADHD medication, excluding the quick-release forms). If you live in Western Canada and are starting this treatment, your participation could help doctors personalize ADHD care in the future.
This trial tests starting a new medication (Methylphenidate or Guanfacine) in young children with moderate or severe ADHD to see how well it works and if it’s safe.
This study looks at whether the medication methylphenidate (often used for ADHD) can help people who have both ADHD and an addiction. It aims to see if the medicine is safe and works well for people with both conditions.
This trial tests whether methylphenidate (a stimulant medicine) helps adults with attention-deficit/hyperactivity disorder (ADHD). It is checking safety and effectiveness for people who can take the immediate-release form of the medicine.
This study tests a medication called Foquest to see if it helps older adults with ADHD. It aims to improve attention and reduce hyperactivity or impulsivity in people aged 65 and above.
Hear when a new Methylphenidate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.